Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 21, 2020 Filed Dec 22, 2020 22:49 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 46,347 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-138671 · tm2039215-1_4seq1.xml · derivative · entry 3 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,347 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 22:49 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
SaleCommon Stock | 46,347 | $22.10 | $1,024,463.36 |
DisclosureSEC source: 0001104659-20-138671 · tm2039215-1_4seq1.xml · nonDerivative · entry 2 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,772 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0000 to $22.2500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 22:49 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionCommon Stock | 46,347 | $12.98 | $601,584.06 |
DisclosureSEC source: 0001104659-20-138671 · tm2039215-1_4seq1.xml · nonDerivative · entry 1 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,653 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · derivative · entry 6 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,347 Underlying: Common Stock · 3,653 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · derivative · entry 5 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F4 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2016. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
SaleCommon Stock | 3,653 | $22.00 | $80,368.56 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · nonDerivative · entry 4 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,772 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0000 to $22.0100, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
SaleCommon Stock | 50,000 | $21.86 | $1,092,895.00 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · nonDerivative · entry 3 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,425 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.5500 to $22.0300, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionCommon Stock | 3,653 | $12.98 | $47,415.94 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · nonDerivative · entry 2 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:20 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
Exercise / conversionCommon Stock | 50,000 | $9.13 | $456,500.00 |
DisclosureSEC source: 0001104659-20-135882 · tm2038590-1_4seq1.xml · nonDerivative · entry 1 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2020. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 16:19 UTC |
PATRICK GREGORY SSr. VP Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-123596 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr. VP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 16:19 UTC |
PATRICK GREGORY SSr. VP Chief Financial Officer
|
SaleCommon Stock | 5,000 | $25.00 | $125,000.00 |
DisclosureSEC source: 0001104659-20-123596 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr. VP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,463 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 16:19 UTC |
PATRICK GREGORY SSr. VP Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $12.98 | $64,900.00 |
DisclosureSEC source: 0001104659-20-123596 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr. VP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:43 UTC |
PATRICK GREGORY SSr. VP, CFO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-122611 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:43 UTC |
PATRICK GREGORY SSr. VP, CFO
|
SaleCommon Stock | 5,000 | $23.00 | $115,000.00 |
DisclosureSEC source: 0001104659-20-122611 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,463 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 17:43 UTC |
PATRICK GREGORY SSr. VP, CFO
|
Exercise / conversionCommon Stock | 5,000 | $12.98 | $64,900.00 |
DisclosureSEC source: 0001104659-20-122611 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. Read SEC document |
| October 15, 2020 Filed Oct 15, 2020 18:04 UTC |
PATRICK GREGORY SSr. VP, CFO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-115378 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 15,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| October 15, 2020 Filed Oct 15, 2020 18:04 UTC |
PATRICK GREGORY SSr. VP, CFO
|
SaleCommon Stock | 15,000 | $20.03 | $300,507.00 |
DisclosureSEC source: 0001104659-20-115378 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,463 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.0000 to $20.5000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 15, 2020 Filed Oct 15, 2020 18:04 UTC |
PATRICK GREGORY SSr. VP, CFO
|
Exercise / conversionCommon Stock | 15,000 | $12.98 | $194,700.00 |
DisclosureSEC source: 0001104659-20-115378 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 16:03 UTC |
Kelly James PatrickExecutive Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $21.13 | $0.00 |
DisclosureSEC source: 0001104659-20-114367 · a4.xml · derivative · entry 1 Kelly James Patrick · CIK 0001506314 · Executive Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on October 12, 2021. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 16:11 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
GiftCommon Stock | 1,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-100179 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,463 Read SEC document |
| August 25, 2020 Filed Aug 28, 2020 16:11 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-100179 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,583 F1 · balance_after: Includes an aggregate of 526 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 20:35 UTC |
Khattar Jack A.Director · President, CEO
|
GrantCommon Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-087366 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,466 Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 16:39 UTC |
Hudson Frederick M.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 8,750 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001104659-20-083754 · a4.xml · derivative · entry 3 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 16:39 UTC |
Hudson Frederick M.Director
|
SaleCommon Stock | 920 | $24.44 | $22,484.80 |
DisclosureSEC source: 0001104659-20-083754 · a4.xml · nonDerivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,041 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020. F2 · balance_after: Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 16:39 UTC |
Hudson Frederick M.Director
|
Exercise / conversionCommon Stock | 8,750 | $2.56 | $22,400.00 |
DisclosureSEC source: 0001104659-20-083754 · a4.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020. F2 · balance_after: Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Read SEC document |
| July 10, 2020 Filed Jul 13, 2020 20:05 UTC |
Khattar Jack A.Director · President, CEO
|
GrantCommon Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-083086 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,841 Read SEC document |
| May 20, 2020 Filed May 20, 2020 18:59 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-20-064386 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 15,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| May 20, 2020 Filed May 20, 2020 18:59 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
SaleCommon Stock | 15,000 | $25.03 | $375,379.50 |
DisclosureSEC source: 0001104659-20-064386 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,057 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.1700, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 20, 2020 Filed May 20, 2020 18:59 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $12.98 | $194,700.00 |
DisclosureSEC source: 0001104659-20-064386 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. Read SEC document |
| May 08, 2020 Filed May 11, 2020 18:42 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-20-059729 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2016. Read SEC document |
| May 08, 2020 Filed May 11, 2020 18:42 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
SaleCommon Stock | 15,000 | $23.14 | $347,034.00 |
DisclosureSEC source: 0001104659-20-059729 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,057 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.0000 to $23.6700, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 08, 2020 Filed May 11, 2020 18:42 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $9.13 | $136,950.00 |
DisclosureSEC source: 0001104659-20-059729 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 00:36 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-037450 · a4.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the KBT Trust Disclosed balance after: 1,068,450 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 13,000 shares were transferred from the KBT Trust to the Reporting Person on March 23, 2020 without consideration and are now owned directly. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 00:36 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-037450 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,216 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 13,000 shares were transferred from the KBT Trust to the Reporting Person on March 23, 2020 without consideration and are now owned directly. F1 · balance_after: The Reporting Person is filing this Form 4 to reflect the fact that 13,000 shares were transferred from the KBT Trust to the Reporting Person on March 23, 2020 without consideration and are now owned directly. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:59 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 9,305 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024891 · a4.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,305 Underlying: Common Stock · 9,305 shares Expires 2030-02-21 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:59 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantCommon Stock | 5,211 | $23.99 | $125,011.89 |
DisclosureSEC source: 0001104659-20-024891 · a4.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,509 F1 · shares: Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 23:51 UTC |
Mottola FrankSr VP, Quality, GMP Oper. & IT
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024920 · a4.xml · derivative · entry 2 Mottola Frank · CIK 0001804567 · Sr VP, Quality, GMP Oper. & IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-02-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:24 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 9,305 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024852 · a4.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,305 Underlying: Common Stock · 9,305 shares Expires 2030-02-21 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:24 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 5,211 | $23.99 | $125,011.89 |
DisclosureSEC source: 0001104659-20-024852 · a4.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,211 F1 · shares: Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:24 UTC |
SIEBERT JOHN MDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 9,305 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024846 · a4.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,305 Underlying: Common Stock · 9,305 shares Expires 2030-02-21 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:24 UTC |
SIEBERT JOHN MDirector
|
GrantCommon Stock | 5,211 | $23.99 | $125,011.89 |
DisclosureSEC source: 0001104659-20-024846 · a4.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,953 F1 · shares: Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:24 UTC |
PATRICK GREGORY SSr.VP,Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024847 · a4.xml · derivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr.VP,Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-21 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
GEMAYEL GEORGESDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 9,305 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024851 · a4.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,305 Underlying: Common Stock · 9,305 shares Expires 2030-02-21 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 5,211 | $23.99 | $125,011.89 |
DisclosureSEC source: 0001104659-20-024851 · a4.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,211 F1 · shares: Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 23:33 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024915 · a4.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-02-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
Barlow CarroleeDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 9,305 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024853 · a4.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,305 Underlying: Common Stock · 9,305 shares Expires 2030-02-21 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 5,211 | $23.99 | $125,011.89 |
DisclosureSEC source: 0001104659-20-024853 · a4.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,211 F1 · shares: Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
Schwabe Stefan K.F.Executive Vice President & CMO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024850 · a4.xml · derivative · entry 2 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-21 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
Khattar Jack A.Director · President, CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 281,250 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024849 · a4.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,250 Underlying: Common Stock · 281,250 shares Expires 2030-02-21 F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:24 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-20-024848 · a4.xml · derivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-02-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.